Shervin Rabizadeh MD
Chair, Department of Pediatrics, Cedars-Sinai Medical Center
Join to view full profile
8700 Beverly BlvdLos Angeles, CA 90048
Phone+1 310-423-5000
Fax+1 310-423-0120
Dr. Rabizadeh is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Gastroenterology, 2004 - 2008- Johns Hopkins UniversityResidency, Pediatrics, 2001 - 2004
Tufts University School of MedicineClass of 2001
Certifications & Licensure
CA State Medical License 2008 - 2028
MD State Medical License 2004 - 2009
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) Start of enrollment: 2022 Feb 10
Roles: Principal Investigator
- A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC) Start of enrollment: 2021 Oct 19
Roles: Principal Investigator
Publications & Presentations
PubMed
- Regional organization of nutrient absorption across the small intestine.Rachel K Zwick, Mark Sharpley, Jérémie Rispal, Shervin Rabizadeh, Dario Boffelli
Nature Reviews. Gastroenterology & Hepatology. 2026-10-01 - 1 citationsThe Safety and Effectiveness of Early Anti-tumor-necrosis-factor Therapy for Penetrating Crohn's Disease Complications in Children.Brad D Constant, Yixuan Feng, Jing Huang, Janet Okraku-Mantey MD, Jeremy Adler
The American Journal of Gastroenterology. 2026-07-01 - 1 citationsGenomic Insights Into Inflammatory Bowel Disease in United States Hispanic Participants: An Ancestry-Focused Study.Ashley H Beecham, Dermot P B McGovern, Steven W Brugger, Mary F Davis, Esther A Torres
Gastroenterology. 2026-05-01
Press Mentions
WebMD: Crohn's Disease and ConstipationDecember 10th, 2025
Fetal Cardiology Expert Joins Cedars-SinaiApril 5th, 2024- Cedars-Sinai Guerin Children's Opens to PatientsAugust 5th, 2022
Grant Support
- Role Of Innate Immunity And STAT3 Activation In Colitis Mouse ModelNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- STAT3 Activation In Bacteria-Induced Murine TH17 Predominant Colonic InflammationNational Institute Of Diabetes And Digestive And Kidney Diseases2008
- STAT3 Activation In Bacteria-Induced Murine TH17 Predominant Colonic InflammationNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: